MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the issuance and sale of an aggregate of ...

Company Overview - Lifeward Ltd is a global market leader in delivering life-changing solutions for rehabilitation, recovery, and enabling individuals with physical limitations or disabilities to pursue their passions [1] - The company designs, develops, and commercializes innovative products across the continuum of care in physical rehabilitation and recovery, including the ReWalk Exoskeleton, AlterG Anti-Gravity System, MyoCycle FES System, and ReStore Exo-Suit [6] - Founded in 2001, Lifeward has operations in the United States, Israel, and Germany [7] Capital Raising Activities - Lifeward has entered into a definitive agreement for a registered direct offering of 1,818,183 ordinary shares at $2.75 per share, with expected gross proceeds of approximately $5.0 million [1][2] - Concurrently, the company will issue unregistered short-term warrants to purchase up to 1,818,183 ordinary shares, exercisable immediately at $2.75 per share for a term of three years [1] - The offering is expected to close on or about January 8, 2025, subject to customary closing conditions [1] - H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering [2] Use of Proceeds - The net proceeds from the offering will be used for continuing commercial efforts, working capital, and general corporate purposes [2] Regulatory and Legal Information - The ordinary shares are being offered pursuant to a shelf registration statement on Form S-3 (Registration No. 333-263984) previously filed with and declared effective by the SEC [3] - The warrants and underlying ordinary shares are being issued in a private placement under Section 4(a)(2) of the Securities Act and Regulation D, and are not registered under the Securities Act or applicable state securities laws [4] Product Portfolio and Mission - Lifeward's mission is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities, empowering them to do what they love [6] - The company's portfolio includes clinically proven and innovative rehabilitation products that deliver functional and health benefits in various settings [6]

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that the Company's Extraordinary General Meeting of Shareholders (the "Meeting), which was originally scheduled to be held on Monday, December 30, 2024 ...

Research at the prestigious Semmelweis University, Budapest, Hungary has led the way in achieving government coverage in Hungary with a code for exoskeleton training that expands access to additional spinal cord injury centers Case processing for individuals will be sponsored by the Hungarian State Insurance on a case-by-case basis MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life- ...

Lifeward Ltd. (NASDAQ:LFWD) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Mike Lawless – Chief Financial Officer Larry Jasinski – Chief Executive Officer Conference Call Participants Swayampakula Ramakanth – H.C. Wainwright Ben Haynor – Lake Street Capital Markets Operator Good day, and welcome to the Lifeward Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being recorded. I wo ...

Lifeward (LFWD) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.56 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -66.67%. A quarter ago, it was expected that this maker of wearable robotic exoskeletons that help paralyzed patients walk would post a loss of $0.53 per share when it actually produced a loss of $0.50, delivering a surprise of 5 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36612 Lifeward Ltd. (Exact name of registrant as specified in charter) Israel Not applicable | --- | --- | |-------------------------- ...

Exhibit 99.1 Lifeward Ltd. Reports Third Quarter 2024 Financial Results Second consecutive quarter of 20 ReWalk systems sold Robust growth in U.S. ReWalk pipeline of approximately 70 qualified leads for potential claim submission with Medicare and other U.S. payors MARLBOROUGH, MA, and YOKNEAM ILLIT, Israel, November 12, 2024 – Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions in physical rehabilitation and recovery, today announced its fi ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, today announced that the Company will release its third quarter 2024 financial results before the markets open on Tuesday, November 12, 2024. Larry Jasinski, Chief Ex ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, announced today that Mike Lawless, Chief Financial Officer, will provide an overview presentation and host one-on-one meetings with investors at the ThinkEquity Confe ...